187 related articles for article (PubMed ID: 11166897)
1. Mumps virus neutralizing antibodies do not protect against reinfection with a heterologous mumps virus genotype.
Nöjd J; Tecle T; Samuelsson A; Orvell C
Vaccine; 2001 Feb; 19(13-14):1727-31. PubMed ID: 11166897
[TBL] [Abstract][Full Text] [Related]
2. Investigation of mumps vaccine failures in Minsk, Belarus, 2001-2003.
Atrasheuskaya AV; Blatun EM; Kulak MV; Atrasheuskaya A; Karpov IA; Rubin S; Ignatyev GM
Vaccine; 2007 Jun; 25(24):4651-8. PubMed ID: 17498853
[TBL] [Abstract][Full Text] [Related]
3. Virus genotypes and responses of serum-specific antibodies in children with primary mumps and mumps reinfection.
Sakata R; Nagita A; Kidokoro M; Kato A; Ogino K
Pediatr Res; 2015 Nov; 78(5):580-4. PubMed ID: 26267156
[TBL] [Abstract][Full Text] [Related]
4. [Specific humoral immunity after single immunization with mumps vaccine: data of a 3-year follow-up].
Otrashevskaia AV; Bukin EK; Krasil'nikov IV; Ignat'ev GM
Vopr Virusol; 2011; 56(3):45-8. PubMed ID: 21786628
[TBL] [Abstract][Full Text] [Related]
5. Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak.
Rubin SA; Qi L; Audet SA; Sullivan B; Carbone KM; Bellini WJ; Rota PA; Sirota L; Beeler J
J Infect Dis; 2008 Aug; 198(4):508-15. PubMed ID: 18558869
[TBL] [Abstract][Full Text] [Related]
6. Mumps vaccine failure investigation in Novosibirsk, Russia, 2002-2004.
Atrasheuskaya AV; Kulak MV; Rubin S; Ignatyev GM
Clin Microbiol Infect; 2007 Jul; 13(7):670-6. PubMed ID: 17484765
[TBL] [Abstract][Full Text] [Related]
7. [Virus strain specific serum neutralizing antibodies in children and adolescents immunized with a Russian mumps vaccine].
Otrashevskaia EV; Krasil'nikov IV; Ignat'ev GM
Vopr Virusol; 2010; 55(6):15-9. PubMed ID: 21381334
[TBL] [Abstract][Full Text] [Related]
8. Mumps outbreaks in a highly vaccinated population: Investigation of a neutralization titre against the current circulating wildtype genotype G5 mumps virus.
Kenny L; O'Kelly E; Connell J; De Gascun C; Hassan J
J Clin Virol; 2016 Jan; 74():8-12. PubMed ID: 26630067
[TBL] [Abstract][Full Text] [Related]
9. [Functional state of specific immunity in children and teenagers vaccinated against mumps].
Otrashevskaia EV; Bukin EK; Krasil'nikov IV; Ignat'ev GM
Vopr Virusol; 2010; 55(4):20-5. PubMed ID: 20886708
[TBL] [Abstract][Full Text] [Related]
10. Assessment of one-dose mumps-containing vaccine effectiveness on wild-type genotype F mumps viruses circulating in mainland China.
Cui A; Zhu Z; Mao N; Si Y; Ma Y; Hu Y; Deng X; Wang L; Zeng L; Zhang Y; Xu W
Vaccine; 2018 Sep; 36(38):5725-5731. PubMed ID: 30122648
[TBL] [Abstract][Full Text] [Related]
11. Analysis of mumps vaccine failure by means of avidity testing for mumps virus-specific immunoglobulin G.
Narita M; Matsuzono Y; Takekoshi Y; Yamada S; Itakura O; Kubota M; Kikuta H; Togashi T
Clin Diagn Lab Immunol; 1998 Nov; 5(6):799-803. PubMed ID: 9801337
[TBL] [Abstract][Full Text] [Related]
12. Serological and phylogenetic evidence of monotypic immune responses to different mumps virus strains.
Rubin S; Mauldin J; Chumakov K; Vanderzanden J; Iskow R; Carbone K
Vaccine; 2006 Mar; 24(14):2662-8. PubMed ID: 16309801
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of mumps virus vaccine candidates matching circulating genotypes in the United States and China.
Zengel J; Phan SI; Pickar A; Xu P; He B
Vaccine; 2017 Jul; 35(32):3988-3994. PubMed ID: 28623030
[TBL] [Abstract][Full Text] [Related]
14. Mumps-specific cross-neutralization by MMR vaccine-induced antibodies predicts protection against mumps virus infection.
Gouma S; Ten Hulscher HI; Schurink-van 't Klooster TM; de Melker HE; Boland GJ; Kaaijk P; van Els CACM; Koopmans MPG; van Binnendijk RS
Vaccine; 2016 Jul; 34(35):4166-4171. PubMed ID: 27372154
[TBL] [Abstract][Full Text] [Related]
15. Cross-neutralization between three mumps viruses & mapping of haemagglutinin-neuraminidase (HN) epitopes.
Vaidya SR; Dvivedi GM; Jadhav SM
Indian J Med Res; 2016 Jan; 143(1):37-42. PubMed ID: 26997012
[TBL] [Abstract][Full Text] [Related]
16. Antigenic differences between vaccine and circulating wild-type mumps viruses decreases neutralization capacity of vaccine-induced antibodies.
Šantak M; Lang-Balija M; Ivancic-Jelecki J; Košutić-Gulija T; Ljubin-Sternak S; Forcic D
Epidemiol Infect; 2013 Jun; 141(6):1298-309. PubMed ID: 22954346
[TBL] [Abstract][Full Text] [Related]
17. Mumps virus reinfection--clinical findings and serological vagaries.
Crowley B; Afzal MA
Commun Dis Public Health; 2002 Dec; 5(4):311-3. PubMed ID: 12564247
[TBL] [Abstract][Full Text] [Related]
18. Mumps virus reinfection is not a rare event confirmed by reverse transcription loop-mediated isothermal amplification.
Yoshida N; Fujino M; Miyata A; Nagai T; Kamada M; Sakiyama H; Ihara T; Kumagai T; Okafuji T; Okafuji T; Nakayama T
J Med Virol; 2008 Mar; 80(3):517-23. PubMed ID: 18205215
[TBL] [Abstract][Full Text] [Related]
19. Genotyping and subtyping of mumps virus isolates from the Indian subcontinent.
Mishra B; Pujhari SK; Dhiman V; Mahalakshmi P; Bharadwaj A; Pokhrel S; Sharma D; Sharma M; Bhatia D; Ratho RK
Arch Virol; 2013 Nov; 158(11):2359-63. PubMed ID: 23685897
[TBL] [Abstract][Full Text] [Related]
20. Epidemiologic and diagnostic evaluation of a recent mumps outbreak using oral fluid samples.
Reid F; Hassan J; Irwin F; Waters A; Hall W; Connell J
J Clin Virol; 2008 Feb; 41(2):134-7. PubMed ID: 18354822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
